Summit Therapeutics (SMMT) Amortizatization of Intangibles (2019 - 2025)
Summit Therapeutics' Amortizatization of Intangibles history spans 7 years, with the latest figure at $3.0 million for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles rose 228.38% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $7.0 million, up 171.97%, while the annual FY2025 figure was $7.0 million, 171.97% up from the prior year.
- Amortizatization of Intangibles reached $3.0 million in Q4 2025 per SMMT's latest filing, up from $1.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.0 million in Q4 2025 to a low of -$2.4 million in Q4 2024.
- Average Amortizatization of Intangibles over 5 years is $738250.0, with a median of $256500.0 recorded in 2021.
- Peak YoY movement for Amortizatization of Intangibles: plummeted 1229.81% in 2024, then soared 637.81% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $340000.0 in 2021, then tumbled by 36.18% to $217000.0 in 2022, then dropped by 4.15% to $208000.0 in 2023, then tumbled by 1229.81% to -$2.4 million in 2024, then soared by 228.38% to $3.0 million in 2025.
- Per Business Quant, the three most recent readings for SMMT's Amortizatization of Intangibles are $3.0 million (Q4 2025), $1.0 million (Q2 2025), and $3.0 million (Q1 2025).